Reference
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:https://doi.org/10.3322/caac.21442
- Key TJ, Schatzkin A, Willett WC, Allen NE, Spencer EA, Travis RC. Diet, nutrition and the prevention of cancer. Public Health Nutr. 2004;7(1A):187–200. doi:https://doi.org/10.1079/phn2003588
- Donaldson MS. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J. 2004;3:19. doi:https://doi.org/10.1186/1475-2891-3-19
- Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, Shoenfeld Y, Lerchbaum E, Llewellyn DJ, Kienreich K, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013;12(10):976–89. doi:https://doi.org/10.1016/j.autrev.2013.02.004
- McCarron DA, Lipkin M, Rivlin RS, Heaney RP. Dietary calcium and chronic diseases. Med Hypotheses. 1990;31(4):265–73. doi:https://doi.org/10.1016/0306-9877(90)90017-9
- Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792–8. doi:https://doi.org/10.1378/chest.128.6.3792
- Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7(9):684–700. doi:https://doi.org/10.1038/nrc2196
- Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW, Jäättelä M. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem. 2002;277(34):30738–45. doi:https://doi.org/10.1074/jbc.M201558200
- Peterlik M, Grant WB, Cross HS. Calcium, vitamin D and cancer. Anticancer Res. 2009;29(9):3687–98.
- Roderick HL, Cook SJ. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer. 2008;8(5):361–75. doi:https://doi.org/10.1038/nrc2374
- Wiers K, Wright MA, Vellody K, Young MR. Failure of tumor-reactive lymph node cells to kill tumor in the presence of immune-suppressive CD34+ cells can be overcome with vitamin D3 treatment to diminish CD34+ cell levels. Clin Exp Metastasis. 1998;16(3):275–82. doi:https://doi.org/10.1023/a:1006501110857
- Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem. 2002;277(33):30337–50. doi:https://doi.org/10.1074/jbc.M201804200
- Matsunawa M, Amano Y, Endo K, Uno S, Sakaki T, Yamada S, Makishima M. The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages. Toxicol Sci. 2009;109(1):50–8. doi:https://doi.org/10.1093/toxsci/kfp044
- Wei H, Jing H, Wei Q, Wei G, Heng Z. Associations of the risk of lung cancer with serum 25-hydroxyvitamin D level and dietary vitamin D intake: a dose-response PRISMA meta-analysis. Medicine (Baltimore). 2018;97(37):e12282. doi:https://doi.org/10.1097/md.0000000000012282
- Liu Y, Chen W, Hu Z-B, Xu L, Shu Y-Q, Pan S-Y, Dai J-C, Jin G-F, Ma H-X, Shen H-B, et al. Plasma vitamin D levels and vitamin D receptor polymorphisms are associated with survival of non-small cell lung cancer. Chin J Cancer Res. 2011;23(1):33–7. doi:https://doi.org/10.1007/s11670-011-0033-3
- Zhou W, Park S, Liu G, Miller DP, Wang LI, Pothier L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC, et al. Dietary iron, zinc, and calcium and the risk of lung cancer. Epidemiology. 2005;16(6):772–9. doi:https://doi.org/10.1097/01.ede.0000181311.11585.59
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi:https://doi.org/10.1007/s10654-010-9491-z
- Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. doi:https://doi.org/10.1016/0197-2456(95)00134-4
- Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:https://doi.org/10.1136/bmj.327.7414.557
- Afzal S, Bojesen SE, Nordestgaard BG. Low plasma 25-hydroxyvitamin D and risk of tobacco-related cancer. Clin Chem. 2013;59(5):771–80. doi:https://doi.org/10.1373/clinchem.2012.201939
- Ananthakrishnan AN, Cheng S–C, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, et al. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014;12(5):821–7. doi:https://doi.org/10.1016/j.cgh.2013.10.011
- Cheng T-YD, Song X, Beresford SAA, Ho GYF, Johnson KC, Datta M, Chlebowski RT, Wactawski-Wende J, Qi L, Neuhouser ML, et al. Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. Cancer Causes Control. 2017;28(10):1053–63. doi:https://doi.org/10.1007/s10552-017-0956-1
- Gromowski T, Gapska P, Scott RJ, Kąklewski K, Marciniak W, Durda K, Lener M, Górski B, Cybulski C, Sukiennicki G, et al. Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence. Int J Cancer. 2017;141(2):336–41. doi:https://doi.org/10.1002/ijc.30740
- Kilkkinen A, Knekt P, Heliovaara M, Rissanen H, Marniemi J, Hakulinen T, Aromaa A. Vitamin D status and the risk of lung cancer: a cohort study in Finland. Cancer Epidemiol Biomarkers Prev. 2008;17(11):3274–8. doi:https://doi.org/10.1158/1055-9965.EPI-08-0199
- Muller DC, Hodge AM, Fanidi A, Albanes D, Mai XM, Shu XO, Weinstein SJ, Larose TL, Zhang X, Han J, et al. No association between circulating concentrations of vitamin D and risk of lung cancer: an analysis in 20 prospective studies in the Lung Cancer Cohort Consortium (LC3). Ann Oncol. 2018;29(6):1468–75. doi:https://doi.org/10.1093/annonc/mdy104
- Ordóñez-Mena JM, Schöttker B, Fedirko V, Jenab M, Olsen A, Halkjaer J, Kampman E, de Groot L, Jansen E, Bueno-de-Mesquita HB, et al. Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium. Eur J Epidemiol. 2016;31(3):311–23. doi:https://doi.org/10.1007/s10654-015-0040-7
- Skaaby T, Husemoen LLN, Thuesen BH, Pisinger C, Jørgensen T, Roswall N, Larsen SC, Linneberg A. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(7):1220–9. doi:https://doi.org/10.1158/1055-9965.Epi-14-0007
- Sun Y-Q, Langhammer A, Wu C, Skorpen F, Chen Y, Nilsen TIL, Romundstad PR, Mai X-M. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study. Eur J Epidemiol. 2018;33(1):67–77. doi:https://doi.org/10.1007/s10654-017-0324-1
- Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study. PLoS One. 2011;6(6):e20796. doi:https://doi.org/10.1371/journal.pone.0020796
- Ong J-S, Gharahkhani P, An J, Law MH, Whiteman DC, Neale RE, MacGregor S. Vitamin D and overall cancer risk and cancer mortality: a Mendelian randomization study. Hum Mol Genet. 2018;27(24):4315–22. doi:https://doi.org/10.1093/hmg/ddy307
- Vojdeman FJ, Madsen CM, Frederiksen K, Durup D, Olsen A, et al. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark. Int J Cancer. 2019;145(2):338–346. doi:https://doi.org/10.1002/ijc.32105
- Wang X, Cui J, Gu J, He H, Li B, Li W. Plasma 25-hydroxyvitamin D deficiency is associated with the risk of non-small cell lung cancer in a Chinese population. CBM. 2015;15(5):663–8. doi:https://doi.org/10.3233/CBM-150506
- Wong YYE, Hyde Z, McCaul KA, Yeap BB, Golledge J, Hankey GJ, Flicker L. In older men, lower plasma 25-hydroxyvitamin D is associated with reduced incidence of prostate, but not colorectal or lung cancer. PLoS One. 2014;9(6):e99954. doi:https://doi.org/10.1371/journal.pone.0099954
- Wu X, Cheng J, Yang K. Vitamin D-related gene polymorphisms, plasma 25-hydroxy-vitamin D, cigarette smoke and non-small cell lung cancer (NSCLC) risk. Int J Mol Sci. 2016;17(10):1597. doi:https://doi.org/10.3390/ijms17101597
- Anic GM, Weinstein SJ, Mondul AM, Mannisto S, Albanes D. Serum vitamin D, vitamin D binding protein, and lung cancer survival. Lung Cancer. 2014;86(3):297–303. doi:https://doi.org/10.1016/j.lungcan.2014.10.008
- Cheng TY, Neuhouser ML. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction. Cancer Causes Control. 2012;23(9):1557–65. doi:https://doi.org/10.1007/s10552-012-0033-8
- Tretli S, Schwartz GG, Torjesen PA, Robsahm TE. Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study. Cancer Causes Control. 2012;23(2):363–70. doi:https://doi.org/10.1007/s10552-011-9885-6
- Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, et al. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007;25(5):479–85. doi:https://doi.org/10.1200/jco.2006.07.5358
- Akiba T, Morikawa T, Odaka M, Nakada T, Kamiya N, Yamashita M, Yabe M, Inagaki T, Asano H, Mori S, et al. Vitamin D supplementation and survival of patients with non-small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Clin Cancer Res. 2018;24(17):4089–97. doi:https://doi.org/10.1158/1078-0432.CCR-18-0483
- Vashi PG, Edwin P, Popiel B, Gupta D. The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer. BMC Cancer. 2015;15(1):1012. doi:https://doi.org/10.1186/s12885-015-2043-x
- Cheng T-YD, Goodman GE, Thornquist MD, Barnett MJ, Beresford SAA, LaCroix AZ, Zheng Y, Neuhouser ML. Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Int J Cancer. 2014;135(9):2135–45. doi:https://doi.org/10.1002/ijc.28846
- Cheng T-YD, LaCroix AZ, Beresford SAA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GY, Neuhouser ML. Vitamin D intake and lung cancer risk in the Women's Health Initiative. Am J Clin Nutr. 2013;98(4):1002–11. doi:https://doi.org/10.3945/ajcn.112.055905
- Patel MI, Wang A, Kapphahn K, Desai M, Chlebowski RT, Simon MS, Bird CE, Corbie-Smith G, Gomez SL, Adams-Campbell LL, et al. Racial and ethnic variations in lung cancer incidence and mortality: results from the women's health initiative. JCO. 2016;34(4):360–8. doi:https://doi.org/10.1200/JCO.2015.63.5789
- Takata Y, Shu X-O, Yang G, Li H, Dai Q, Gao J, Cai Q, Gao Y-T, Zheng W. Calcium intake and lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2013;22(1):50–7. doi:https://doi.org/10.1158/1055-9965.Epi-12-0915-t
- Hu J, Johnson KC, Mao Y, Xu T, Lin Q, Wang C, Zhao F, Wang G, Chen Y, Yang Y, et al. A case-control study of diet and lung cancer in northeast China. Int J Cancer. 1997;71(6):924–31. doi:https://doi.org/10.1002/(SICI)1097-0215(19970611)71:6<924::AID-IJC2>3.0.CO;2-#
- Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586–91. doi:https://doi.org/10.1093/ajcn/85.6.1586
- Li K, Kaaks R, Linseisen J, Rohrmann S. Dietary calcium and magnesium intake in relation to cancer incidence and mortality in a German prospective cohort (EPIC-Heidelberg). Cancer Causes Control. 2011;22(10):1375–82. doi:https://doi.org/10.1007/s10552-011-9810-z
- Mahabir S, Forman MR, Dong YQ, Park Y, Hollenbeck A, Schatzkin A. Mineral intake and lung cancer risk in the NIH-American Association of Retired Persons Diet and Health study. Cancer Epidemiol Biomarkers Prev. 2010;19(8):1976–83. doi:https://doi.org/10.1158/1055-9965.EPI-10-0067
- Redaniel MT, Gardner MP, Martin RM, Jeffreys M. The association of vitamin D supplementation with the risk of cancer in postmenopausal women. Cancer Causes Control. 2014;25(2):267–71. doi:https://doi.org/10.1007/s10552-013-0328-4
- Zhu K, Knuiman M, Divitini M, Hung J, Lim EM, Cooke BR, Walsh JP. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study. Nutr Res. 2019;67:100–7. doi:https://doi.org/10.1016/j.nutres.2019.03.010
- Robsahm TE, Tretli S, Torjesen PA, Babigumira R, Schwartz GG. Serum 25-hydroxyvitamin D levels predict cancer survival: a prospective cohort with measurements prior to and at the time of cancer diagnosis. CLEP. 2019;11:695–705. doi:https://doi.org/10.2147/CLEP.S207230
- Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr. 2008;87(4):1087S–91s. doi:https://doi.org/10.1093/ajcn/87.4.1087S
- Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342–57. doi:https://doi.org/10.1038/nrc3691
- Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181(10):7090–9. doi:https://doi.org/10.4049/jimmunol.181.10.7090
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM, Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30. doi:https://doi.org/10.1210/jc.2011-0385
- Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin. 2008;24(1):139–49. doi:https://doi.org/10.1185/030079908x253519
- Piotrowska A, Wierzbicka J, Żmijewski MA. Vitamin D in the skin physiology and pathology. Acta Biochim Pol. 2016;63(1):17–29. doi:https://doi.org/10.18388/abp.2015_1104
- Van Cromphaut SJ, Rummens K, Stockmans I, Van Herck E, Dijcks FA, Ederveen AGH, Carmeliet P, Verhaeghe J, Bouillon R, Carmeliet G. Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res. 2003;18(10):1725–36. doi:https://doi.org/10.1359/jbmr.2003.18.10.1725
- Kállay E, Bises G, Bajna E, Bieglmayer C, Gerdenitsch W, Steffan I, Kato S, Armbrecht HJ, Cross HS. Colon-specific regulation of vitamin D hydroxylases-a possible approach for tumor prevention. Carcinogenesis. 2005;26(9):1581–9. doi:https://doi.org/10.1093/carcin/bgi124
- Nittke T, Selig S, Kallay E, Cross HS. Nutritional calcium modulates colonic expression of vitamin D receptor and pregnane X receptor target genes. Mol Nutr Food Res. 2008;52 Suppl 1(Suppl 1):S45–S51. doi:https://doi.org/10.1002/mnfr.200700200